Article Text

21-hydroxylase deficiency in Italy: a distinct distribution pattern ofCYP21 mutations in a sample from southern Italy
  1. A BOBBA,
  2. E MARRA,
  3. S GIANNATTASIO
  1. CNR, Centro di Studio sui Mitocondri e Metabolismo Energetico, Via Amendola 165/A, 70126 Bari, Italy
  2. Dipartimento di Biomedicina dell’Età Evolutiva, Università di Bari, Italy
  3. Dipartimento di Pediatria, Università Federico II, Napoli, Italy
    1. A IOLASCON,
    2. F MONNO
    1. CNR, Centro di Studio sui Mitocondri e Metabolismo Energetico, Via Amendola 165/A, 70126 Bari, Italy
    2. Dipartimento di Biomedicina dell’Età Evolutiva, Università di Bari, Italy
    3. Dipartimento di Pediatria, Università Federico II, Napoli, Italy
      1. S DI MAIO
      1. CNR, Centro di Studio sui Mitocondri e Metabolismo Energetico, Via Amendola 165/A, 70126 Bari, Italy
      2. Dipartimento di Biomedicina dell’Età Evolutiva, Università di Bari, Italy
      3. Dipartimento di Pediatria, Università Federico II, Napoli, Italy

        Statistics from Altmetric.com

        Request Permissions

        If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

        Editor—Congenital adrenal hyperplasia (CAH) is an autosomal recessive genetic disease, the main cause of which is steroid 21-hydroxylase (21OH) deficiency.1 The classical phenotype of the disease includes a severe salt wasting (SW) form in which both cortisol and aldosterone synthesis is impaired, and a mild form with normal aldosterone synthesis, commonly known as simple virilising (SV). In most white populations, an incidence of 1:5000 to 1:15 000 has been reported for the severe classical forms.2 The late onset form (LO), also called non-classical (NC), is characterised by the appareance of symptoms of excessive androgen activity late in life with an incidence of 1:100 to 1:1000 persons.3

        The steroid 21-hydroxylase locus has a complex structure with two genes, CYP21P andCYP21, located on the short arm of chromosome 6 within the HLA class III gene region dowstream of each of the two genes encoding the fourth component of complement,C4A and C4B, respectively. Small exchanges of sequences, a process known as gene conversion, could create many of the disease causing mutated alleles by transferring some of the deleterious mutations from the pseudogene to the CYP21 gene.4 5 Owing to the complexity of the locus, complete characterisation of mutantCYP21 alleles in patients with 21OH deficiency could be performed either by direct sequencing or by a mutation scanning method, such as non-radioactive DNA single strand conformation polymorphism analysis of all exons and exon/intron junctions.6 To date, deletion and several sequence aberrations of the CYP21 gene have been reported to cause steroid 21-hydroxylase deficiency in different populations including Italians, with 10 mutations being the most frequent.7-11

        In cases of other well characterised recessive diseases, such as phenylketonuria and cystic fibrosis, clear heterogeneity of distribution of the relative frequencies of the disease mutation has been …

        View Full Text